These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22438982)

  • 1. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.
    Tasneem A; Aberle L; Ananth H; Chakraborty S; Chiswell K; McCourt BJ; Pietrobon R
    PLoS One; 2012; 7(3):e33677. PubMed ID: 22438982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MEDLINE categorization algorithm.
    Darmoni SJ; Névéol A; Renard JM; Gehanno JF; Soualmia LF; Dahamna B; Thirion B
    BMC Med Inform Decis Mak; 2006 Feb; 6():7. PubMed ID: 16464249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using ClinicalTrials.gov to understand the state of clinical research in pulmonary, critical care, and sleep medicine.
    Todd JL; White KR; Chiswell K; Tasneem A; Palmer SM
    Ann Am Thorac Soc; 2013 Oct; 10(5):411-7. PubMed ID: 23987571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of registered clinical trials in otolaryngology from 2007 to 2010: ClinicalTrials.gov.
    Witsell DL; Schulz KA; Lee WT; Chiswell K
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):692-9. PubMed ID: 24107478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results.
    Cepeda MS; Lobanov V; Berlin JA
    Clin Trials; 2013 Apr; 10(2):347-8. PubMed ID: 23539114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000-2020.
    Gresham G; Meinert JL; Gresham AG; Piantadosi S; Meinert CL
    Trials; 2022 Oct; 23(1):858. PubMed ID: 36203212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Completeness of ClinicalTrials.gov.
    Stergiopoulos S; Getz KA; Blazynski C
    Ther Innov Regul Sci; 2019 May; 53(3):307-317. PubMed ID: 30048602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of automated and human assignment of MeSH terms on publicly-available molecular datasets.
    Ruau D; Mbagwu M; Dudley JT; Krishnan V; Butte AJ
    J Biomed Inform; 2011 Dec; 44 Suppl 1(Suppl 1):S39-S43. PubMed ID: 21420508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
    Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
    Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of NLM medical subject headings with the MeSH2010 thesaurus in the PORTAL-DOORS system.
    Taswell C
    Stud Health Technol Inform; 2010; 159():255-8. PubMed ID: 20543446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indexing Publicly Available Health Data with Medical Subject Headings (MeSH): An Evaluation of Term Coverage.
    Marc DT; Zhang R; Beattie J; Gatewood LC; Khairat SS
    Stud Health Technol Inform; 2015; 216():529-33. PubMed ID: 26262107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.
    Cahan A; Anand V
    PLoS One; 2017; 12(11):e0185886. PubMed ID: 29107973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.
    Hirsch BR; Califf RM; Cheng SK; Tasneem A; Horton J; Chiswell K; Schulman KA; Dilts DM; Abernethy AP
    JAMA Intern Med; 2013 Jun; 173(11):972-9. PubMed ID: 23699837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstacles to the reuse of study metadata in ClinicalTrials.gov.
    Miron L; Gonçalves RS; Musen MA
    Sci Data; 2020 Dec; 7(1):443. PubMed ID: 33339830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of studies of pharmacist services registered in ClinicalTrials.gov.
    Dammo N; Harpe SE
    J Am Pharm Assoc (2003); 2020; 60(4):609-617. PubMed ID: 31902662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manual versus machine: How accurately does the Medical Text Indexer (MTI) classify different document types into disease areas?
    Moore DAQ; Yaqub O; Sampat BN
    PLoS One; 2024; 19(3):e0297526. PubMed ID: 38478542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.
    Pasquali SK; Lam WK; Chiswell K; Kemper AR; Li JS
    Pediatrics; 2012 Nov; 130(5):e1269-77. PubMed ID: 23027172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency analysis of medical concepts in clinical trials and their coverage in MeSH and SNOMED-CT.
    Varghese J; Dugas M
    Methods Inf Med; 2015; 54(1):83-92. PubMed ID: 25346408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.